Albuterol Sulfate Solution
Product Images NDC 62135-827

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 62135-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Albuterol Sulfate Inhalation 0pt021mg Carton Label)

Image Description (Albuterol Sulfate Inhalation 0pt021mg Carton Label)
Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL packaging label from Chartwell Rx, LLC. The label shows a 30 x 3 mL sterile unit-dose vial count. It states the solution concentration as 0.021% (0.63 mg per 3 mL), for respiratory inhalation. The label includes dosage details, manufacturer information, barcode, and regulatory text.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation 0pt042mg Carton Label)

Image Description (Albuterol Sulfate Inhalation 0pt042mg Carton Label)
Packaging label for Albuterol Sulfate Inhalation Solution, 0.042% (1.25 mg / 3 mL) by Chartwell RX, LLC. The label indicates the solution is sterile and intended for respiratory inhalation. Each carton contains 30 sterile unit-dose vials of 3 mL each. The label includes NDC 62135-827-84 and storage and usage instructions.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Figure 1)

Image Description (Albuterol Sulfate Inhalation Figure 1)
A line graph titled '% Change from Pre-Dose FEV1 Intent-to-Treat Population Day 1' showing percentage change over 6 hours from pre-dose. It compares treatment effects of albuterol 1.25 mg, albuterol 0.63 mg, and placebo, with albuterol treatments showing higher % change than placebo throughout the time period.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Figure 2)

Image Description (Albuterol Sulfate Inhalation Figure 2)
A line graph titled '% Change from Pre-Dose FEV1, Intent-to-Treat Population Day 28' showing the percentage change over time in hours from pre-dose up to 6 hours. It compares three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo, with albuterol treatments showing greater percent change than placebo across the time points.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Picture 1)

Image Description (Albuterol Sulfate Inhalation Picture 1)
An instructional illustration showing the assembly process of a respiratory inhalation solution device. The image depicts a vial being inserted or connected to a mouthpiece or inhalation apparatus, corresponding to a product like Albuterol Sulfate solution for inhalation.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Picture 2)

Image Description (Albuterol Sulfate Inhalation Picture 2)
An instructional line drawing showing the connection between an inhalation solution device and a nebulizer mouthpiece or tubing. The image appears to demonstrate how to attach or assemble parts of a respiratory inhalation solution device.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Picture 3)

Image Description (Albuterol Sulfate Inhalation Picture 3)
An instructional illustration showing a person using a respiratory inhalation solution device. The person is depicted putting their mouth on the inhalation mouthpiece while holding the device with one hand, demonstrating how to properly use the inhalation apparatus.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Picture 4)

Image Description (Albuterol Sulfate Inhalation Picture 4)
Illustration showing the correct method to use an inhalation device. It depicts a person inhaling from a mouthpiece connected to a small solution container, demonstrating how to administer Albuterol Sulfate respiratory solution by inhalation.*
FDA Label Image

Image Description (Albuterol Sulfate Inhalation Structure)

Image Description (Albuterol Sulfate Inhalation Structure)
Chemical structure diagram of albuterol sulfate showing its molecular components, including the benzene ring, hydroxyl groups, and the sulfate salt form, as indicated by the formula notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.